Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidar

Showing results (321-330 of 325) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 325 results.
ESMO Open|January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancerE J van Dijk, M M Smeenk, F Bensch, et al.
Arthritis Care & Research|October 26, 2018
International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working GroupMartijn A H Oude Voshaar, Zofia Das Gupta, Johannes W J Bijlsma, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2024
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanomaRik J Verheijden, Femke H Burgers, Josephine C Janssen, et al.
Science Translational Medicine|October 26, 2021
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohortRaphael Carapito, Richard Li, Julie Helms, et al.
Frontiers in Medicine|September 26, 2022
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseasesCarla Gaggiano, Antonio Vitale, Abdurrahman Tufan, et al.
Pageof 33

Showing results (321-330 of 325) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 325 results.
ESMO Open|January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancerE J van Dijk, M M Smeenk, F Bensch, et al.
Arthritis Care & Research|October 26, 2018
International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working GroupMartijn A H Oude Voshaar, Zofia Das Gupta, Johannes W J Bijlsma, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2024
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanomaRik J Verheijden, Femke H Burgers, Josephine C Janssen, et al.
Science Translational Medicine|October 26, 2021
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohortRaphael Carapito, Richard Li, Julie Helms, et al.
Frontiers in Medicine|September 26, 2022
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseasesCarla Gaggiano, Antonio Vitale, Abdurrahman Tufan, et al.
Pageof 33